Semax vs Selank: Which Russian Nootropic Peptide Is Right for You?

Two peptides. One lab in Moscow. Completely opposite effects on the brain.

Semax and Selank were developed side by side at the Institute of Molecular Genetics in the 1980s — both grew out of ACTH peptide research, both were approved for clinical use in Russia, and both ended up in the hands of biohackers worldwide. But put them head to head and you quickly realize they're solving different problems.

Semax is activating. It drives BDNF and NGF synthesis, amplifies dopaminergic tone, and enhances the kind of focused, motivated cognition that high performers want during demanding cognitive work. Selank is calming. It modulates GABA-A activity, slows enkephalin breakdown, and delivers anxiolytic clarity without sedation — the brain's natural anti-anxiety system without benzodiazepine risk.

Neither peptide is "better." They target completely different bottlenecks in cognitive performance, and which one you need depends entirely on what's holding you back: a lack of neural drive and plasticity, or an excess of stress and anxiety that's crowding out your cognition.

This guide breaks down exactly how each peptide works at the mechanistic level, lays out the clinical and research case for each, and walks through the specific use cases where each excels — including whether stacking them makes sense for you.

For a broader overview of the cognitive peptide landscape, see the Complete Guide to Cognitive Peptides and Nootropics.

What Is Semax?

Semax is a synthetic heptapeptide with the sequence Met-Glu-His-Phe-Pro-Gly-Pro. Structurally, it's based on the ACTH(4-7) fragment — the four-amino-acid core of adrenocorticotropic hormone responsible for its CNS activity — with a Pro-Gly-Pro (PGP) C-terminus extension added to protect it from enzymatic degradation and extend its bioactivity. The full molecule has a molecular weight of approximately 708 Da.

Despite being derived from ACTH, Semax is not a steroid and has no hormonal activity. ACTH itself is a 39-amino-acid peptide produced by the pituitary gland primarily to stimulate cortisol release from the adrenal cortex. Semax uses only the neuropeptide signaling fragment of ACTH — the part that acts in the brain — without the steroidogenic tail. It doesn't stimulate cortisol. It doesn't act on the HPA axis. It acts on the central nervous system directly.

Origin and clinical status: Semax was developed at the Institute of Molecular Genetics in Moscow in the 1980s as part of Soviet-era neuropeptide research. It has been approved in Russia and several post-Soviet states for the treatment of traumatic brain injury (TBI), ischemic stroke recovery, and cognitive decline associated with aging and vascular pathology. These are real regulatory approvals based on clinical data, not marketing claims.

Delivery: Semax is primarily administered intranasally — absorbed through the olfactory epithelium and transported directly into the brain via the olfactory nerve pathway, bypassing first-pass metabolism almost entirely. Subcutaneous injection is also used and may produce slightly different kinetics, but intranasal is the dominant route in both clinical and biohacking contexts.

Pharmacokinetics: The plasma half-life of intranasal Semax is approximately 30 minutes — it degrades quickly in circulation. But this understates its functional duration considerably. The downstream effects — particularly BDNF and NGF upregulation — persist for hours to days after a single dose. The acute peptide clears fast; the neurotrophin cascade it triggers does not.

For the full mechanistic and clinical deep-dive, see the Semax: Complete Science on Focus, Memory, and Neuroprotection article.

What Is Selank?

Selank is a synthetic heptapeptide with the sequence Thr-Lys-Pro-Arg-Pro-Gly-Pro. It is a structural analogue of tuftsin, a naturally occurring tetrapeptide (Thr-Lys-Pro-Arg) produced from the Fc region of IgG immunoglobulin. The same Pro-Gly-Pro C-terminus extension found in Semax was added to Selank as well — protecting it from rapid enzymatic cleavage and giving it a longer functional half-life than native tuftsin. Molecular weight is approximately 751 Da.

Origin and clinical status: Like Semax, Selank was developed at the Institute of Molecular Genetics in Moscow — the same research group, the same era. It has been approved in Russia for the treatment of generalized anxiety disorder and asthenic syndrome (a clinical diagnosis for chronic fatigue, low energy, and cognitive impairment following stress or illness). This clinical approval is based on human trial data, not anecdotal reports.

Key distinguishing feature: Selank is anxiolytic without being sedating. This is the characteristic that makes it genuinely unusual in the pharmacology of anxiety treatment. Benzodiazepines suppress anxiety by broadly enhancing GABA-A activity — effective but sedating, tolerance-forming, and associated with withdrawal. Selank modulates the GABAergic system at a different point, producing calm without CNS depression, and does not appear to generate tolerance or physical dependence at standard doses.

Delivery: Like Semax, Selank is primarily administered intranasally. The intranasal route provides rapid CNS access via the olfactory pathway, with onset typically noticed within 15–30 minutes. The plasma half-life is similar to Semax — approximately 30 minutes — but functional anxiolytic effects persist considerably longer than the peptide's circulation time.

Cognitive effects: Selank's reputation is primarily anxiolytic, but it also has documented cognitive effects — particularly in individuals whose cognitive performance is impaired by anxiety or chronic stress. When the HPA axis is chronically overactivated, glucocorticoid load suppresses hippocampal function and working memory. By reducing anxiety and stress reactivity, Selank partially restores the cognitive performance floor in stress-impaired individuals.

For the full mechanistic and clinical deep-dive, see the Selank: Peptide for Anxiety and Cognitive Enhancement article.

Mechanisms: How They Differ

This is where Semax and Selank diverge completely — and understanding the mechanisms is the key to choosing correctly.

Semax: Activating and Neuroplasticity-Driven

1. BDNF and NGF upregulation

The most important mechanism for Semax's cognitive effects is its robust upregulation of brain-derived neurotrophic factor (BDNF) and nerve growth factor (NGF). Dolotov et al. (2006) demonstrated that Semax administration increases BDNF mRNA expression in the hippocampus and frontal cortex — the precise brain regions governing memory formation, executive function, and learning consolidation. BDNF is often called the brain's "fertilizer" because it promotes synaptogenesis, dendritic branching, and long-term potentiation — the biological substrate of learning. NGF performs a parallel role for cholinergic neurons specifically. The downstream result is enhanced neuroplasticity: the brain becomes more capable of forming and reinforcing new connections.

2. Dopaminergic enhancement

Semax increases dopaminergic tone in the striatum, enhancing both D1 and D2 receptor sensitivity and accelerating dopamine turnover. This is a key mechanism for its focus-enhancing, motivation-amplifying effects. Dopaminergic drive is central to the brain's reward-prediction circuitry and goal-directed behavior. More dopaminergic tone means better sustained attention, higher working memory capacity, and stronger motivation to engage with cognitively demanding tasks. Semax also modulates serotonergic pathways, contributing to mood stabilization alongside its activating effects.

3. DAG signaling and synaptic potentiation

Semax activates diacylglycerol (DAG) signaling pathways, which activate protein kinase C (PKC). PKC phosphorylation of AMPA receptors increases their sensitivity and membrane insertion rates, producing a form of synaptic potentiation that enhances information transmission at existing synapses. This is a more acute mechanism than BDNF upregulation — it contributes to the faster-onset cognitive sharpening that users notice within 30–60 minutes of a dose.

4. Neuroprotection

Semax reduces glutamate excitotoxicity — the mechanism by which excess glutamate overstimulates NMDA receptors and kills neurons, particularly in ischemic conditions. Meshalkina et al. (2012) published data on Semax's neuroprotective effects in ischemia models, consistent with its clinical approval for stroke recovery. For biohackers, this is less immediately relevant than the cognitive enhancement mechanisms, but it speaks to the compound's safety profile: a peptide that protects neurons is unlikely to be neurotoxic.

Net subjective profile: Activating, focus-enhancing, slightly stimulating. Users typically report increased motivation, mental clarity, faster processing speed, and improved working memory. Some describe it as "caffeine-like but smoother" — without the jitteriness or crash. The activation profile is real: Semax genuinely increases neural drive.

Selank: Calming and Anxiolytic

1. GABA-A positive modulation

Selank modulates GABA-A receptor activity in a manner that is functionally similar to benzodiazepines but mechanistically distinct. Critically, Selank does NOT bind directly to the GABA-A receptor as a full agonist. It appears to modulate the benzodiazepine binding site allosterically — enhancing GABAergic tone without the full agonism that causes tolerance, receptor downregulation, and withdrawal. This is the pharmacological reason why Selank can produce anxiolytic effects at acute doses without generating physical dependence. It enhances inhibitory tone in the amygdala and limbic system — reducing the neural "alarm signal" — without globally suppressing CNS activity.

2. Enkephalin metabolism modulation

Selank slows the enzymatic degradation of Met-enkephalin, one of the brain's endogenous opioid peptides. Met-enkephalin acts at delta and mu opioid receptors to produce mild analgesic and anxiolytic effects as part of the body's natural stress response system. By extending the lifetime of endogenous enkephalins, Selank maintains opioid tone without exogenous opioids — producing a mild, natural calming effect that complements the GABAergic mechanism. This is an important nuance: Selank doesn't create new opioid activity, it preserves the body's own.

3. IL-6 modulation and the stress-cytokine axis

Selank modulates interleukin-6 (IL-6) expression without broad immune suppression. This matters because IL-6 is a key mediator in the stress-cytokine axis — the bidirectional signaling loop between chronic psychological stress and systemic inflammation. Chronically elevated IL-6 contributes to neuroinflammation, HPA axis dysregulation, and the cognitive impairment pattern seen in burnout and chronic anxiety. By normalizing IL-6 dynamics, Selank addresses one of the upstream drivers of stress-induced cognitive decline.

4. Serotonin modulation

Selank increases serotonin synthesis and turnover in the forebrain. Serotonergic tone in the prefrontal cortex and hippocampus is associated with emotional regulation, impulse control, and the cognitive flexibility needed for adaptive problem-solving. This mechanism partially explains why Selank produces "calm clarity" rather than simply reducing anxiety while leaving cognition flat. It adds a mild pro-cognitive dimension to its anxiolytic profile.

Net subjective profile: Calming, anti-anxiety, mildly cognitively clarifying, non-sedating. Users typically report reduced mental noise, lower baseline anxiety, improved ability to focus without rumination, and better stress tolerance. Unlike benzodiazepines, Selank does not produce a "fuzzy" or cognitively blunted state. The clarity it delivers is quiet rather than sharp.

Semax vs Selank: Side-by-Side Comparison

When to Choose Semax

Semax is the right choice when the bottleneck in your cognitive performance is insufficient drive, energy, or neuroplasticity — not anxiety or stress. If you're functioning relatively well emotionally but want more processing speed, sharper focus, stronger working memory, or better learning consolidation, Semax is the tool.

High-performance cognitive work. Semax's dopaminergic enhancement and BDNF upregulation make it well-suited for periods of intensive intellectual output — exam prep, deep creative work, complex analysis, or any extended period of demanding cognitive engagement. The dopaminergic drive helps maintain sustained attention across long sessions; the BDNF upregulation builds lasting neuroplasticity over repeated cycles.

Post-TBI or stroke recovery. This is the use case with the strongest clinical backing. Semax's neuroprotective profile — reducing glutamate excitotoxicity and upregulating neurotrophins — aligns directly with the mechanisms of TBI and ischemic recovery. Its clinical approval in Russia for these indications is based on actual human trial data. For biohackers who've experienced head injuries or are supporting recovery, this is the most evidence-backed application.

Low energy with cognitive fog. BDNF deficiency — driven by chronic stress, sleep deprivation, sedentary lifestyle, or aging — manifests as mental fatigue, difficulty concentrating, and reduced cognitive resilience. Semax directly addresses this pattern via neurotrophin upregulation. If your cognitive symptoms are characterized more by flatness and low drive than by anxiety and rumination, Semax fits.

Athletes wanting a mental edge. For competitive athletes or high-output training phases, the combination of dopaminergic enhancement and neuroplasticity support provides a genuine performance edge without the stimulant risks of amphetamines or high-dose caffeine. Semax doesn't spike heart rate, doesn't interfere with sleep at appropriate dosing times, and doesn't cause the cortisol dysregulation associated with stimulant overuse.

Neuroplasticity and brain optimization. For biohackers specifically focused on long-term cognitive optimization — not just acute performance — the BDNF/NGF upregulation is the most interesting long-term mechanism. BDNF drives synaptogenesis and synaptic strengthening. Over repeated Semax cycles, the cumulative effect may include genuinely improved learning capacity and memory consolidation, not just acute focus enhancement.

Cautions: Semax is activating. This means it's not appropriate before sleep — taking it in the evening will likely delay sleep onset and reduce sleep quality. In individuals predisposed to anxiety, the dopaminergic activation can occasionally amplify rather than suppress anxiety. If you tend toward anxious cognition rather than low-energy cognition, Selank may be a better fit — or consider stacking (see below).

Standard dosing protocol: 300–600 mcg intranasally per session, 2–3 drops per nostril, administered in the morning or immediately before a demanding cognitive session. Typical cycling: 10 days on, 20 days off to allow receptor sensitivity to normalize. Some users run shorter 5-day cycles; longer cycles beyond 10 days require more time off.

When to Choose Selank

Selank is the right choice when the bottleneck in your cognitive performance is anxiety, chronic stress, or HPA axis overactivation — not a lack of drive. If your brain is already working hard but anxiety, rumination, or stress is degrading the quality of that output, Selank addresses the upstream problem.

Generalized, social, or performance anxiety. The GABAergic modulation and enkephalin preservation mechanisms make Selank directly anxiolytic — it works on the same biological system as benzodiazepines, but without full GABA-A agonism. For individuals with chronic anxiety patterns who want a non-pharmaceutical, non-sedating option, Selank's clinical approval for generalized anxiety disorder is a meaningful data point. It has been tested in humans for this indication.

Stress-driven cognitive impairment. Chronic psychological stress suppresses hippocampal function via glucocorticoid overload, depletes dopamine and serotonin reserves, and chronically elevates inflammatory cytokines. The result is cognitive impairment that looks like "brain fog" — slow processing, poor working memory, difficulty forming new memories. Selank addresses this at multiple nodes: reducing the anxiety that drives HPA overactivation, modulating IL-6, and boosting serotonergic tone in the forebrain.

High-functioning anxiety. The "anxious high-achiever" who thinks too much, second-guesses decisions, and burns cognitive resources on rumination rather than output is the paradigmatic Selank user. Selank quiets the mental noise without sedating the intellect. The result is often a subjective experience of cognitive clarity that wasn't accessible under the weight of anxiety — not because cognition itself was enhanced, but because the anxiety tax was removed.

Sleep quality and evening use. Unlike Semax, Selank is well-suited to evening administration. Its calming, non-sedating profile reduces the hyperarousal and rumination that interfere with sleep onset in anxious individuals. For people with stress-driven insomnia (the kind where you're tired but your mind won't stop), a low dose of Selank 30–60 minutes before bed can meaningfully improve both sleep latency and sleep quality. For a deeper look at sleep-supporting peptide protocols, see DSIP: The Complete Science on Sleep, Recovery, and Stress Hormones.

Coming off benzodiazepines. This is an advanced use case requiring careful medical supervision, but Selank's GABAergic modulation without full receptor agonism positions it theoretically as a support compound during benzodiazepine tapering. It provides some GABAergic tone to buffer the rebound hyperexcitability of BZD withdrawal without replacing the mechanism that caused the dependence. This is not a simple swap and requires medical oversight — but it illustrates the mechanistic specificity of Selank's anxiolytic action.

Cautions: At higher doses, mild sedation is possible — Selank is not reliably stimulation-neutral at 500+ mcg. It is not a performance enhancer in the Semax sense: don't expect increased drive, motivation, or processing speed. Its cognitive benefits are indirect (anxiety reduction improves cognition) rather than direct (cognitive enhancement independent of anxiety status). Theoretical immune modulation through the tuftsin-derived structure exists but is not well-characterized at standard anxiolytic doses.

Standard dosing protocol: 250–500 mcg intranasally per session. For acute anxiety management, 1–2 cycles of 10 days per month with 2–3 weeks off. For chronic anxiety or daily low-dose use, 100 mcg per day appears well-tolerated with minimal tolerance risk. Evening dosing (30–60 min before bed) works well for sleep and stress recovery applications.

Can You Stack Semax and Selank?

Yes — and it's one of the most well-regarded stacks in the nootropic community precisely because the two peptides operate on entirely different mechanism nodes.

The rationale: Semax provides the BDNF/dopaminergic "activation floor" — the neural drive, focus, and learning capacity. Selank provides the GABAergic/enkephalin "calming layer" — reducing anxiety and stress reactivity. Together, the net effect is alert calm: the motivated clarity of an optimal performance state, rather than the jittery activation of stimulants or the sedated ease of anxiolytics alone. This is pharmacologically similar to the L-theanine + caffeine combination that became mainstream in the nootropics world: one compound provides the energy, the other smooths the rough edges.

The target user: The "anxious high-achiever" profile — someone with genuine cognitive ambition and high drive, but whose output is degraded by anxiety, rumination, or stress reactivity. This person often describes "knowing what they want to do but not being able to settle enough to do it." Selank addresses the anxiety component; Semax addresses the performance component.

Stacking protocols:

Protocol A — Daily split: Selank in the early morning (reduce baseline anxiety before the day begins) + Semax mid-morning (ride the calm into the cognitive performance window). 30–60 minutes between doses gives Selank time to establish its calming effect before Semax's activation kicks in.

Protocol B — Separate cycles: Run Selank first (10-day anxiety-normalization cycle), then after a week off, run Semax (10-day neuroplasticity cycle). This avoids any potential interaction concerns and allows you to assess each compound's individual contribution before combining.

This multi-node stacking logic — two complementary peptides at different mechanism points — is the same principle behind the CJC-1295 / Mod-GRF + Ipamorelin GH stack: one peptide loads the system, the other fires it.

Peptide Stacking Guide — $14.99 If you're thinking about combining Semax and Selank (or any other peptide stack), the Peptide 101 Stacking Guide covers the full logic of multi-peptide protocols — how to sequence, how to cycle, and how to troubleshoot. It's the most practical resource we have for anyone moving beyond single-peptide use. Get the Stacking Guide →

Side Effects and Safety

Both Semax and Selank have favorable tolerability profiles in the clinical literature. Neither compound has shown hepatotoxicity, nephrotoxicity, or organ damage in animal or human studies. Both have been used clinically in Russia with an established human safety record.

Semax-specific: The most commonly reported adverse effect is nasal irritation at higher doses, particularly with repeated intranasal administration. At doses above 600 mcg, some users report overstimulation — restlessness, mild anxiety, or difficulty with sleep if dosed too late in the day. Individuals predisposed to anxiety should start at the lower end of the dosing range (300 mcg) and assess tolerance before escalating.

Selank-specific: Mild sedation is possible at doses above 400–500 mcg, particularly in the evening. Occasional light-headedness has been reported, most often associated with rapid absorption from the nasal mucosa. Selank's tuftsin-derived structure theoretically gives it some immune-modulating properties, but the clinical significance of this at standard anxiolytic doses is not well-characterized.

Both compounds: Semax and Selank are classified as research chemicals in the United States and European Union. Neither is FDA-approved or available by prescription in Western countries. They are not scheduled substances — they are not illegal to possess — but they are also not approved for human therapeutic use.

Storage: Lyophilized (freeze-dried) powder should be stored at -20°C until reconstitution. Once reconstituted in bacteriostatic water, the solution should be refrigerated (2–8°C) and used within 2–4 weeks. For reconstitution protocol details, see the How to Reconstitute Peptides guide.

Frequently Asked Questions

Is Semax or Selank better for anxiety?

Selank is specifically better for anxiety. Its GABAergic modulation mechanism directly targets the anxiety circuitry — the same system benzodiazepines act on, but without full agonism. Semax has no anxiolytic mechanism; in fact, its dopaminergic activation can occasionally worsen anxiety in predisposed individuals. If anxiety is the primary complaint, Selank is the correct choice.

Can Semax worsen anxiety?

Yes, in predisposed individuals. Semax's dopaminergic enhancement is activating — it increases neural drive and arousal. In individuals with underlying anxiety disorders or high baseline sympathetic tone, this activation can amplify anxiety rather than suppress it. This is not universal: many anxious people use Semax without issue, particularly at lower doses. But it's a real risk to be aware of. If you're anxiety-prone, start at 300 mcg, assess your response over 2–3 doses before escalating, and consider adding Selank to buffer the activation.

Are Semax and Selank legal in the US?

Both are research chemicals in the United States — not FDA-approved for human use, not scheduled as controlled substances. Possession is not illegal under federal law, but they cannot be prescribed, labeled for human consumption, or sold as supplements. Their regulatory status is similar to most peptides in the biohacking space: technically available as research reagents, used by self-experimenters at their own discretion.

How do they compare to conventional nootropics or smart drugs?

Semax is most analogous to a stimulant-class nootropic — something like a cleaner, BDNF-driven alternative to amphetamines or racetams. It amplifies drive and performance without the cardiovascular effects of stimulants. Selank is most analogous to an anxiolytic nootropic — in the category with L-theanine or low-dose buspirone, but more targeted and effective. They are not interchangeable with these compounds, but the functional category comparison is useful for orientation.

How long until you feel effects?

Semax: Acute cognitive effects (focus, sharpness, motivation) typically appear within 30–60 minutes of intranasal administration. BDNF/NGF upregulation effects — improved learning capacity, neuroplasticity, sustained cognitive improvement — develop over days to weeks of consistent use. Selank: Anxiolytic effects typically appear within 15–30 minutes, making it one of the faster-acting anxiety interventions available. The calm, reduced mental noise, and improved stress tolerance are usually noticeable within the first session.

Conclusion

Semax and Selank are genuinely different tools for genuinely different problems.

Semax is for the brain that needs more: more drive, more BDNF, more neuroplasticity, more capacity to learn and retain. It's the right choice for cognitive performance work, post-injury recovery, low-energy cognitive fog, and anyone whose bottleneck is insufficient neural activation.

Selank is for the brain that needs less: less anxiety, less rumination, less stress reactivity. It's the right choice for generalized anxiety, stress-driven cognitive impairment, sleep quality, and anyone whose performance is limited by emotional noise rather than intellectual capacity.

The stack is for the brain that needs both — the anxious high-achiever who wants peak performance without the anxiety tax. Selank builds the calm foundation; Semax builds on top of it.

Neither is better. The right one depends entirely on your specific bottleneck. Understanding that distinction is what separates effective peptide use from guesswork — and that's exactly what Peptide 101 is built to help with.

Peptide 101: Complete Bundle — $19.99 The complete framework for understanding how to layer cognitive peptides — and every other peptide category — into a coherent protocol. Covers mechanisms, dosing, cycling, and stacking logic across the full peptide library. Get the Complete Bundle →

This content is for educational purposes only and does not constitute medical advice. Semax and Selank are research peptides and are not FDA-approved for any human therapeutic indication. All dosing information is derived from published research and community-observed protocols — not approved clinical guidelines. Consult a qualified healthcare provider before beginning any peptide protocol.